Immediate Impact

1 by Nobel laureates 4 from Science/Nature 57 standout
Sub-graph 1 of 23

Citing Papers

Comprehensive review of CRISPR-based gene editing: mechanisms, challenges, and applications in cancer therapy
2024 Standout
Therapeutic advances of targeting receptor tyrosine kinases in cancer
2024 Standout
8 intermediate papers

Works of Phillip B. Murray being referenced

Augmentor α and β (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: Hierarchy and specificity of ligand–receptor interactions
2015
Heparin is an activating ligand of the orphan receptor tyrosine kinase ALK
2015

Author Peers

Author Last Decade Papers Cites
Phillip B. Murray 91 69 29 67 2 173
Hanwen Bai 83 50 19 39 5 156
William Luther 79 75 37 45 4 174
Andrew Morrison 139 120 38 45 4 281
Gang Li 160 49 35 86 5 241
Gudny Eiriksdottir 116 67 62 58 5 266
Yen Tran 148 32 47 46 5 236
Lintong Li 180 75 38 127 3 288
Elliot Kahen 172 87 35 45 7 295
Sabine Gijsen 118 30 66 22 3 198
Nabahet Ameur 122 37 57 67 5 237

All Works

Loading papers...

Rankless by CCL
2026